Robot surgery may cut complication rates in penile cancer treatment
NCT ID NCT07378670
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether robot-assisted groin lymph node removal causes fewer serious side effects than standard open surgery in 80 men with penile cancer. The goal is to reduce wound healing problems and other complications while still effectively controlling the cancer. Participants are randomly assigned to one of the two surgical approaches and followed for up to 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PENILE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité- Universitätsmedizin Berlin
NOT_YET_RECRUITINGBerlin, Germany
-
Ludwig Maximilian University Hospital
NOT_YET_RECRUITINGMünchen, Germany
-
Medical Faculty Mannheim
NOT_YET_RECRUITINGMannheim, Germany
-
University Hospital Carl Gustav Carus
NOT_YET_RECRUITINGDresden, Germany
-
University Hospital Tübingen
RECRUITINGTübingen, Germany
-
University Hospital Ulm
NOT_YET_RECRUITINGUlm, Germany
-
University Medical Center of Johannes Gutenberg-University
NOT_YET_RECRUITINGMainz, Germany
-
University Medicine Rostock
NOT_YET_RECRUITINGRostock, Germany
-
Universitätsklinikum Erlangen
NOT_YET_RECRUITINGErlangen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Penis transplants could restore form and function for wounded warriors
- New drug combo targets HPV-Driven cancers in phase II trial
- Double antibody attack: early trial combines immune and Growth-Signal blockers against advanced cancers
- Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
- Promising drug cocktail aims to shrink penile cancer before surgery